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Abstract. In this work we describe the transformation of synthetic route of the antie-
pileptic drug candidate Sumepirin starting from discovery stage. Initial method included 
six step process requiring two steps of purification using colon chromatography and has 
poor overall yield of target compound. The process developed is convenient, scalable, 
technological and meet the most of conditions of green chemistry. The overall yield was 
increased up to 62.5% in four steps without colon chromatography purification which 
allows to obtain the target compound with purity of 99.5+% which is especially important 
for the active ingredient.
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Introduction
The social and medical signifi-
cance of epilepsy is determined by its high 
prevalence. Epilepsy is one of  the most 
common chronic diseases of the nervous 
system in the world, which affects both 
children and adults. 5% of the population 
suffers at least one epileptic seizure dur-
ing their lifetime. In 70% of cases, epilepsy 
debuts in childhood and adolescence. Pa-
tients with epilepsy may have mental prob-
lems including personality changes specific 
to the disease associated with a mnestic-
intellectual defect, affective disorders and 
so-called epileptic psychoses. According 
to the WHO, about 50 million people suf-
fer from epilepsy, which is about 0.5–1% 
of the world’s population (https://www.
who.int/news-room/fact-sheets/detail/
epilepsy). Approximately 5 million new 
cases are diagnosed worldwide each year. 
Moreover, 30% of patients with epilepsy 
are pharmacoresistant [1]. On the other 
hand, existing antiepileptic drugs have a lot 
of side effects including ataxia, decreased 
mental ability, drowsiness, dizziness, di-
gestive disorders, etc. [2]. Development 
of effective and safe drugs may significantly 
improve the quality of life of patients suf-
fering from epilepsy.
Sumepirin 1 is  a novel antiepileptic 
drug candidate developed in the Scien-
tific and Educational Center of Pharma-
ceutics of the Kazan Federal University and 
having pronounced antiseizure effect and 
improved safety profile. This compound 
is pyridoxine-based molecule with residue 
of methanesulfonic acid in the 6th position 
of pyridoxine ring (Fig. 1). 
It has successfully passed preclinical 
studies in  the  framework of  State pro-
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gram of  Russian Federation «Develop-
ment of  the Pharmaceutical and Medi-
cal Industry» and is planned to undergo 
the clinical trials. As Sumepirin entered 
preclinical studies stage an urgent need 
of the optimization of its method of syn-
thesis arised. Preclinical phase involves 
study of chronical toxicity of a drug can-
didate both in small (e.g. mice or rats) 
and large (rabbits) animals. The duration 
of these experiments depends on the ex-
pected duration of the course of the drug. 
Antiepileptic drugs are usually taken for 
an extended period of time: from months 
to years. That means that chronical toxic-
ity should be studied at least for 6 month 
of everyday administration of a drug. Dur-
ing the discovery stage a general method 
of synthesis was used which allows prepa-
ration of diverse set of 6-substitued pyri-
doxine derivatives. This method is not suit-
able for large-scale synthesis as required 
at preclinical trials. This required the de-
velopment of more convenient and scalable 
synthetic approach.
Experimental 
Unless otherwise stated, chemicals are 
obtained from the commercial suppliers 
and were used without further purification. 
1H and 13C NMR spectra were recorded 
on a “Bruker AVANCE 400” at operating 
frequencies of 400.13 and 100.62 MHz, 
respectively. Chemical shifts were meas-
ured with reference to the residual peak 
of the solvent (DMSO-d6, 
1H, 2.50 ppm, 
13C, 39.52 ppm; CDCl3, 
1H, 7.26 ppm, 13C, 
77.16 ppm). Coupling constants (J) are 
given in Hertz (Hz). The following abbre-
viations are used to describe coupling: s 
= singlet; d = doublet; t = triplet. Melting 
points were determined using a Stanford 
Research Systems MPA-100 OptiMelt melt-
ing point apparatus and are uncorrected. 
For TLC analysis, silica gel plates from 
Sorbfil (Krasnodar, Russia) were used with 
UV light (254 nm) as a developing agent. 
Column chromatography was performed 
on silica gel (60–200 mesh) from Acros.
High-resolution mass spectroscopy 
mass spectra were obtained on a quad-
rupole time-of-flight (t, qTOF) AB Sciex 
Triple TOF 5600 mass spectrometer using 
turbo-ion spray source (nebulizer gas ni-
trogen, positive ionization polarity, needle 
voltage 5500 V). Recording of the spectra 
was performed in “TOF MS” mode with 
a collision energy of 10 eV, declustering po-
tential of 100 eV and resolution more than 
30,000 full-width half-maximum. Samples 
with the analyte concentration 5 µmol/L 
were prepared by dissolving the test com-
pounds in a mixture of methanol (HPLC-
UV Grade, LabScan) and water (LC–MS 
Grade, Panreac) in 1:1 ratio.
Compounds 3, 4, 5 and 6 were obtained 
according to published procedures [3–5] 
without any modifications, unless other-
wise is stated.
I.  Optimized method of  synthe-
sis of  6-(hydroxymethyl)-3,3,8-trime-
thyl-1,5-dihydro-[1,3]dioxepino[5,6-c]
pyridin-9-ol (4). 143 g (684 mmol) com-
pound 3 is added to the 2-liter double-








Fig. 1. Structure of Sumepirin 1
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magnetic stirring bar and a thermometer. 
Solution of 14 g (342 mmol) of sodium 
hydroxide in 342 ml of distilled water and 
120 ml of freshly distilled formaldehyde 
solution (37% wt., 1641 mmol, stabilized 
with 5% methanol) is added to the reac-
tion vessel. Mixture is flushed with argon 
and reaction is carried out under inert at-
mosphere at 70 °C for about 5 h. The reac-
tion is controlled by TCL on silica (elu-
ent CHCl3:MeOH = 10:1) until the spot 
of starting material completely disappears. 
After reaction is finished, reaction mixture 
is cooled down to the room temperature 
and neutralized by the 1M solution of hy-
drochloric acid to the pH = 6.5. A seed 
of water-insoluble crystalline form of 4 
(10 mg) is added to the solution. Solution 
is then transferred into the 2-liter beaker 
and left overnight to  achieve complete 
crystallization. The  precipitate formed 
is filtered off, washed 3 times with the 100 
ml of distilled water and dried to obtain 
154 g (94%) of compound 4 as pale yellow 
solid; m.p. 182–183 °C. 1H NMR (DMSO-
d6), δ, ppm: 1.41 (s, 6Н), 2.33 (s, 3Н), 4.42 
(s, 2Н), 4.80 (s, 2Н), 4.82 (s, 2Н). Spectrum 
is in accordance with the previously pub-
lished [4].
II. Synthesis of sodium (9-hydroxy-
3,3,8-trimethyl-1,5-dihydro-[1,3]
dioxepino[5,6-c]pyridin-6-yl)meth-
anesulfonate (7) starting from 
6-(chloromethyl)-3,3,8-trimethyl-1,5-di-
hydro-[1,3]dioxepino[5,6-c]pyridin-9-yl 
acetate (6). In the 100 ml round bottom 
flask equipped with mechanical stirring 
bar a solution of 1.0 g (3.34 mmol) of com-
pound 6 in 20 ml of dichloromethane and 
solution of 0.8 g (6.67 mmol) of sodium 
sulfite in 30 ml of water were added. 0.01 g 
(0.03 mmol) of TBAB were added to the re-
action mixture and the reaction was car-
ried out at room temperature while vig-
orous stirring for 10 h. Then water layer 
is separated from the organic and water 
is removed under reduced pressure. Dry 
solid residue is extracted with 3×100 ml 
of hot isopropyl alcohol. Alcohol extract 
is evaporated until 30 ml left and white pre-
cipitate formed is filtered off and washed 
with 10 ml of cold isopropyl alcohol. Af-
ter drying 0.66 g (61%) of compound 7 
was obtained as white solid; m.p. 197 °C 
(decomp.). NMR 1H (400 MHz, DMSO-
d6), δ, ppm: 1.38 (s, 6Н, C(СН3)2), 2.30 (s, 
3Н, СН3), 3.82 (s, 2Н, СН2S), 4.79 (s, 2Н, 
СН2), 4.90 (s, 2Н, СН2). NMR 
13С {1H} 
(100  MHz, DMSO-d6), δ, ppm: 19.28, 
23.73, 57.47, 59.11, 60.97, 101.45, 132.07, 
134.18, 140.97, 143.25, 146.78. HRМS-ESI: 
found [М+Н]+ 326.0667, C12H16NNaO6S, 
calculated [М+Н]+ 326.0669.
III. Synthesis of  sodium (5-hy-
droxy-3,4-bis(hydroxymethyl)-6-meth-
ylpyridin-2-yl)methanesulfonate (1) 
starting from sodium (9-hydroxy-
3,3,8-trimethyl-1,5-dihydro-[1,3]
dioxepino[5,6-c]pyridin-6-yl)methane-
sulfonate (7). 0.66 g (2.03 mmol) of com-
pound 7 is dissolved in 10 ml concentrated 
hydrochloric acid. The solution was stirred 
for 1 h at room temperature. After this in-
soluble NaCl filtered off (solubility of NaCl 
in concentrated HCl solution is 0.1% wt.) 
and 40 ml of isopropanol is added to the fil-
trate. After standing for 1 hour a crystalline 
precipitate is formed. The solid is filtered 
off, washed with 10 ml of cold isopropanol 
and dried. Dry solid is dissolved in 15 ml 
of distilled water and titrated with 0.1 M 
NaOH solution until pH = 7.2. After drying 
0.57 g (98%) of compound 1 was obtained 
as  white solid; m.p. 265  °C (decomp.). 
NMR 1H (400 MHz, DMSO-d6), δ, ppm: 
2.31 (s, 3H, CH3), 4.04 (s, 2H, CH2), 4.51 
(d, 3JHH = 6.3 Hz, 2H, CH2), 4.78 (s, 2H, 
CH2), 5.17 (t, 
3JHH = 6.3 Hz, 1H, OH). NMR 
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13С {1H} (100 MHz, DMSO-d6), δ, ppm: 
19.33, 56.80, 57.16, 57.21, 132.07, 132.74, 
143.31, 145.04, 148.94. HRМS-ESI: found 
[М+Н]+ 286.0354, C9H12NNaO6S, calcu-
lated [М+Н]+ 286.0356.
IV. Modified synthesis of  (9-ace-
toxy-3,3,8-trimethyl-1,5-dihydro-[1,3]
dioxepino[5,6-c]pyridin-6-yl)methyl 
acetate (10). 1-liter double-necked round 
bottom flask equipped with magnetic stir-
ring bar and effective reflux condenser 
is charged with 90 g (376 mmol) of com-
pound 4, 55 ml of  triethylamine (395 
mmol) and 400 ml of dichloromethane. 
28 ml of acetyl chloride (395 mmol) in 100 
ml of dichloromethane is charged into drop 
funnel which is then attached to the flask. 
Acetyl chloride is added dropwise to the re-
action mixture while stirring to maintain 
slow boiling. After whole amount is added 
reaction mixture is stirred for additional 
0.5 h and then extracted with 3×200 ml 
of distilled water and washed with brine. 
Organic layer is separated, dried over an-
hydrous sodium sulfate and evaporated. 
Residue is  dried under vacuum to  ob-
tain 119 g (98%) of 10 as viscous liquid 
of yellow to light brown color which may 
crystallize upon long standing. NMR 1H 
(400 MHz, DMSO-d6), δ, ppm: 1.48 (s, 6H, 
CH3), 2.09 (s, 3H, CH3), 2.35 (s, 6H, CH3), 
4.72 (s, 2H, CH2), 4.89 (s, 2H, CH2), 5.13 (s, 





anesulfonate (7) starting from (9-ace-
toxy-3,3,8-trimethyl-1,5-dihydro-[1,3]
dioxepino[5,6-c]pyridin-6-yl)methyl ac-
etate (10). Solutions of 100 g (309 mmol) 
of bis-acetate 10 in 400 ml of methanol 
and 59 g (464 mmol) of sodium sulfite 
in 600 ml of distilled water are prepared 
separately. Solutions are added to the 2 liter 
round bottom flask equipped with mag-
netic stirring bar while stirring. The re-
sulting mixture is stirred for 6 h at room 
temperature. The solvents are evaporated 
under vacuum following the same workup 
procedure as described in  synthesis II. 
The product is dried under vacuum to ob-
tain 57 g (57%) of 7 as white solid; m.p. 
197 °C (decomp.). NMR 1H (400 MHz, 
DMSO-d6), δ, ppm: 1.38 (s, 6Н, C(СН3)2), 
2.30 (s, 3Н, СН3), 3.82 (s, 2Н, СН2S), 4.79 
(s, 2Н, СН2), 4.90 (s, 2Н, СН2). NMR 
13С 
{1H} (100 MHz, DMSO-d6), δ, ppm: 19.28, 
23.73, 57.47, 59.11, 60.97, 101.45, 132.07, 
134.18, 140.97, 143.25, 146.78. HRМS-ESI: 
found [М+Н]+ 326.0667, C12H16NNaO6S, 
calculated [М+Н]+ 326.0669.
V I .  S y n t h e s i s  o f   ( 5 - h y -
droxy-3,4-bis(hydroxymethyl)-6-methyl-
pyridin-2-yl)methanesulfonic acid (11) 
starting from 6-(hydroxymethyl)-3,3,8-tri-
methyl-1,5-dihydro-[1,3]dioxepino[5,6-c]
pyridin-9-ol (4). 15 liter glass reactor 
equipped with anchor-type stirrer, reflux 
condenser, heating jacket, thermom-
eter and pH-meter is loaded with 1565 g 
(6540 mmol) of compound 4 and solution 
of 1262 g (9810 mmol) if sodium sulfite 
in 5.5 liters of distilled water. The reaction 
mixture is stirred under reflux conditions 
for 5 h while maintaining pH at a range be-
tween 8.0 and 9.0 by the addition of small 
portions of concentrated hydrochloric acid 
(about 300 ml of acid was used). The reac-
tion is controlled by TCL on silica (elu-
ent CHCl3:MeOH = 3:1) until the  spot 
of  starting material completely disap-
pears. Then reaction mixture is  cooled 
down to the room temperature and neu-
tralized with concentrated hydrochloric 
acid to the pH = 6.5 during 30 minutes. 
The precipitate of by-product is formed 
and is  filtered off. Filtrate is  acidified 
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to the pH = 1.0 with concentrated hydro-
chloric acid. Acidified mixture is evapo-
rated under vacuum until mushy residue 
is obtained while absorbing SO2 formed 
with solution of sodium hydroxide. Resi-
due is heated up until boiling and small 
portions of water are added until clear so-
lution obtained. After cooling to 0°C crys-
talline precipitate of product 11 is formed. 
It is filtered off and washed with 300 ml 
of  ice-cold distilled water. After drying 
1120 g (65%) of product 11 is obtained 
as off-white to pale yellow solid. Filtrate 
is evaporated until dryness and extracted 
with 1 liter of boiling water followed by hot 
filtration. After cooling this filtrate to 0 °C 
second portion 223 g (13%) of product 
11 was isolated additionally. Overall yield 
1343 g (78%); m.p. 250 °С (decomp). NMR 
1H (400 MHz, DMSO-d6), δ, ppm: 2.56 (s, 
3Н, СН3), 4.27 (s, 2Н, СН2S), 4.70 (s, 2Н, 
СН2), 4.90 (s, 2Н, СН2). NMR 
13С {1H} 
(100  MHz, DMSO-d6), δ, ppm.: 14.74, 
51.57, 55.52, 56.19, 136.44, 138.79, 141.50, 
142.95, 151.62. HRМS-ESI: found [М+Н]+ 
264.0537, C9H13NO6S, calculated [М+Н]
+ 
264.0536.
VI. Synthesis of sodium (5-hydroxy-
3,4-bis(hydroxymethyl)-6-methyl pyridin-
2-yl)methanesulfonate (1) starting from 
(5-hydroxy-3,4-bis(hydroxymethyl)-
6-methylpyridin-2-yl)methanesulfonic ac-
id (11). 15 liter glass reactor equipped with 
anchor-type stirrer is loaded with 1343 g 
(5100 mmol) of compound 11 and solution 
of 204 g (5100 mmol) of sodium hydrox-
ide in 2.5 liters of water. Mixture is stirred 
at room temperature during 6 minutes un-
til clear solution is obtained. Then 12 liters 
of isopropyl alcohol is added and white 
precipitate is formed immediately. Solid 
is filtered off, washed with twice with 1 liter 
of isopropyl alcohol and dried to obtain 
1427 g (98%) of product 1 as a white solid 
with purity >99.5% (HPLC); m.p. 265 °C 
(decomp.). NMR 1H (400 MHz, DMSO-
d6), δ, ppm: 2.31 (s, 3H, CH3); 4.04 (s, 2H, 
CH2), 4.51 (d, 
3JHH = 6.3 Hz, 2H, CH2); 4.78 
(s, 2H, CH2); 5.17 (t, 
3JHH = 6.3 Hz, 1H, 
OH). NMR 13С {1H} (100 MHz, DMSO-d6), 
δ, ppm: 19.33, 56.80, 57.16, 57.21, 132.07, 
132.74, 143.31, 145.04, 148.94. HRМS-ESI: 
found [М+Н]+ 286.0354, C9H12NNaO6S, 
calculated [М+Н]+ 286.0356.
Results and discussion
The  starting point of  our research 
was synthetic method described below 
in Scheme 1.
As can be seen overall yield is slightly 
greater than 18%. Moreover, two steps (c 
and d) require column chromatography. 
In case of intermediate 5 chromatography 
is needed to separate ester by the benzyl 
group from the desired compound. This 
also explains poor yield at this step.
As  substance 3  has hydroxymethyl 
group in  the  para- position in  relation 
to the phenol OH. It makes possible to in-
vestigate the possibility of functionalization 
of this scaffold via meta- quinon methide 
intermediate. The reactivity of orto- and 
para-quinon methides intermediates is well 
studied in non-heterocyclic aromatic struc-
tures [7, 8]. But we can barely find any data 
on its heterocyclic analogs.
Acetyl esters 8 and 9 are among usu-
al quinone methide precursors [9, 10] 
(Fig. 2). 
In  this connection bis-acetic ester 
8 that was synthesized earlier in our re-
search group [6] was a good starting point 
for the optimization of synthetic route. 
It has straightforward synthesis with no 
need of chromatographic purification. It 
was shown that use of acetyl chloride in-
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stead of acetic anhydride as an acylating 
agent in synthesis of 8 dramatically reduces 
the reaction time from 30 hours [6] to only 
0.5 hour with no need of refluxing condi-
tions (Scheme 2).
It was shown that bis-acetyl ester 10 can 
react with primary and secondary amines 
in  alcohol media [11]. An  attempt was 
made to investigate reactivity of 10 toward 
sulfur-containing nucleophile such as so-
dium sulfite. Very poor solubility of sodium 
sulfite in almost any organic media includ-
ing alcohols became the main barrier for 
this reaction. Usual methods like two-phase 
reaction system (H2O/CH2Cl2) with phase 
transfer catalyst gave very low yields even 
after prolonged reaction time. However, it 
was an indication of the principal possibil-
ity of such a reaction. The best results (57% 
yield of 6) were achieved using mixed sol-
vent water/MeOH in 3:2 ratio by the vol-
ume. In  this mixture both components 
of the reaction have significant solubility. 
Replacement of MeOH with EtOH or any 
other alcohol significantly reduces the solu-
bility of sodium sulfite slowing the reaction 
and reducing the yield. The development 
of this synthetic step not only reduces total 
amount of steps, it allows to avoid chro-
matographic purification of  intermedi-
ates 5 and 6 which are no longer needed. 
With this implementation total yield was 
increased from 18% to 38% with no prin-
cipal limitation for the scaling-up.
Another optimization was made dur-
ing the scaling-up of the process. Original 
method of the synthesis of 4 includes ex-
traction with ethanol during the workup. 
After the evaporation of ethanol 4 is ob-
















































6 (90%)7 (61%)1 (98%)
Scheme 1. Reagents and conditions: (a) (CH3)2CO, HCl, 0 °C, 12 h [3]; (b) CH2O, NaOH, H2O, 
70 °C, 60 h [4]; (c) Ac2O, Et3N, CH2Cl2, r.t., 30 h [5]; (d) MsCl, Et3N, CHCl3, 0 °C to r.t., 10 h [5]; 
(e) Na2SO3, TBAB, CH2Cl2/H2O, r.t., 10 h; (f) HCl, H2O, r.t., 1 h 
* — yield according to non-optimized method [4]
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bility in water and melting point of 161–
163  °C.  However, the  crystalline solid 
precipitates from water solutions of 4 after 
long standing. It was found to have simi-
lar NMR spectra as 4 and melting point 
of 182–183 °C which indicates another 
crystalline form of the same compound. 
This finding allows to alter the workup pro-
cedure of the synthesis of 4 which consists 
in seed induces precipitation of product 
from the neutralized mother liquor. This 
alteration not only simplified the proce-
dure but also improved the yield up to 94% 
at this step due to more complete precipita-
tion. The use of freshly distilled formalde-
hyde solution and use of more concentrat-
ed reaction mixture (less solvent) allows 
to dramatically reduce the reaction time 
from 60 to 6 hours.
In some examples o- and p- hydroxym-
ethylphenols may play a role of the quinon 
methide precursors. This examples are usu-
ally limited to the reaction with C-nucle-
ophiles like base-activated 2-nitropropane 
[12] or potassium cyanide [13]. Reactions 
of pyridoxine with different alcohols are 
described yielding corresponding 4’ — es-
ters [14]. The latter do not have much prac-
tical significance due to very long reaction 
time (about 96 hours).
The original work [15] and its modern 
reiteration [16] has evidence of the pos-
sibility of direct reaction between p-hy-
droxymethylphenol and sodium hydro-
sulfite. This reaction has a good yield and 
requires refluxing in the water media for 
only 8 hours. Possible application of this 
method to the direct synthesis of com-
pound 7 starting from 4 allows reducing 
the total amount of steps.
It was found that reaction of 4 with 
sodium hydrosulfite is not possible as pH 
of the reaction mixture is slightly acidic 
(pH = 4–5) and it is enough the remove 
the dimethylketal protecting group. The re-
placement of  hydrosulfite with sulfite 
gave the first results as  it makes possi-
ble to achieve the partial conversion of 4 
to 7. The conversion was not complete 
even after prolonged refluxing. Usually 
it reaches 60–70% in 6 hours and does 
not change after. This process is believed 
to be reversible (Fig. 3) and the conver-
sion observed corresponds to the equilib-
rium. The changes of pH of the reaction 
mixture were observed during the process: 
from pH = 11 at the start to pH = 13.5 
at the equilibrium. The addition of small 
amounts of acid to control pH makes it 
possible to reach complete conversion. It 
was found that optimal pH for the reaction 
is in range between 8.0 and 9.0. Under this 
pH controlled conditions reaction com-
pletes in 5 hours of refluxing.
It was found to be unpractical to iso-





















Scheme 2. Reagents and conditions:  
(a) AcCl, NEt3, CH2Cl2, r.t. 0.5 h; (b) Na2SO3, H2O/MeOH, r.t., 6 h
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step as  it requires extraction with huge 
amount of isopropyl alcohol. Deprotec-
tion step may be done by the acidification 
of the reaction mixture from the previous 
step with the  isolation of  sulfonic acid 
11 as it has limited solubility in cold wa-














































Scheme 3. Reagents and conditions: (a) (CH3)2CO, HCl, 0 °C, 12 h [3];  
(b) CH2O, NaOH, H2O, 70 °C, 6 h; (c) Na2SO3, H2O, pH = 8.0–9.0, reflux, 5 h;  
(d) HCl, pH = 1.0, 0.5 h, r.t.; (e) NaOH, H2O, r.t., 0.1 h 
* — yield according to optimized method of synthesis (see experimental)
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Conclusions
Thus, the total yield of the final method 
of synthesis of the antiepileptic drug can-
didate Sumepirin 1 starting prom pyri-
doxine hydrochloride was increased from 
18% to 62.5%. As the result of optimiza-
tion the amount of steps was reduced from 
six to four. It is also important that this 
method is environment-friendly: at first 
step reagent (acetone) is used as a solvent 
and any other step is carried out in water 
media; good level of atom economy was 
achieved due to elimination of chloride and 
acetyl protecting or leaving groups from 
the synthetic route. Unfortunately, it does 
not seem to be possible not to use the di-
methylketal protecting group because OH 
groups in 4’ and 6’ positions of pyridoxine 
ring have very similar reactivity.
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